Evommune, Inc. Common Stock (EVMN)

EBITDA

-$100.36M

TTM · Period ending: · USD

EVMN logo

EVMN EBITDA

Latest reported-$100.36M
EVMN EBITDA (-$33.00M → -$100.36M)
High-resolution chart · PNG

EVMN ebitda history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Evommune, Inc. Common Stock EBITDA — Annual fiscal periods (USD)
Period endingEBITDA (USD)
-79,682,000
-65,487,000
-32,995,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.